Showing results (631-640 of 645) with videos related to
Sort By:
Pageof 65
Archives of Neurology|December 15, 2004
Analysis of the PINK1 gene in a large cohort of cases with Parkinson diseaseEkaterina Rogaeva, Janel Johnson, Anthony E Lang, et al.Neurology|April 13, 2012
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseI H Richard, M P McDermott, R Kurlan, et al.The New England Journal of Medicine|August 3, 2022
Trial of Cinpanemab in Early Parkinson's DiseaseAnthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.Journal of Medicinal Chemistry|March 12, 1999
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridinesR J Chorvat, R Bakthavatchalam, J P Beck, et al.Neurology|February 13, 2019
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseasesAlberto J Espay, Joaquin A Vizcarra, Luca Marsili, et al.Nature Communications|June 9, 2021
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speechKeith A Josephs, Joseph R Duffy, Heather M Clark, et al.Annals of Neurology|May 29, 2009
SNCA variants are associated with increased risk for multiple system atrophySonja W Scholz, Henry Houlden, Claudia Schulte, et al.Brain : a Journal of Neurology|July 29, 2024
Parkinson's disease variant detection and disclosure: PD GENEration, a North American studyLola Cook, Jennifer Verbrugge, Tae-Hwi Schwantes-An, et al.Journal of Gynecology Obstetrics and Human Reproduction|June 20, 2018
Management of endometriosis: CNGOF/HAS clinical practice guidelines - Short versionP Collinet, X Fritel, C Revel-Delhom, et al.Frontiers in Neurology|July 19, 2021
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of CareBrent Bluett, Alexander Y Pantelyat, Irene Litvan, et al.Pageof 65